---
title: "Final Update Antipsychotics Project"
format: 
  revealjs:
    theme: [default, custom.scss]
    slide-number: true
incremental: true
editor: source

---
## "Differentially Methylated Regions <br> associated with antipsychotic treatment <br> <br> <br> <br> <br> Martens Summer Seminar <br> June 17, 2024" {background-color="black" background-image="img/summerFlowers.jpg" background-size="cover" background-opacity="0.7"}

---

## Looking back <br>

-   Focus on response, rather than cross-sectional methylation status
-   Real-world studies are also challenging
-   Median study duration 6 weeks, maximum 13 weeks (PMID:37159349)
-   Treatment discontinuation rate (TDR) lower for monotherapy vs polypharmacy
-   Risperidone highest TDR and shortest Time to discontinuation (TTD) (PMID: 35770081)

::: footer
Leucht et al.(2013) **World Psychiatry**; Zhang et al.(2022) **Frontiers in Pharmacology**, 2022
:::

---
#Sample Selection 
:::

::: {.column width="50%"}



:::

::: {.column width="50%"}

- Same samples for both groups
- Medication-free added to Specific Effects group
- Monotherapy with olanzapine, quetiapine, risperidone
:::

:::

---

## Differentially Methylated Region (DMR) Analysis  <br>

::: nonincremental
-   Aim 1: To identify DMRs associated with the common and specific effects mediated by these APs.

:::

::: footer
Martens Summer Seminar June 17, 2024
:::


---

## DNA Methylation & Antipsychotics <br> <br>

<p>[Olanzapine, Quetiapine, Risperidone]{.highlight}</p>

::: nonincremental


:::

::: footer
Martens Summer Seminar June 17, 2024
:::

---

## Methods: Sample Selection {.nostretch}

{width="45%" fig-align="center"}

---

## Methods: Models


---

## EWAS and Regional Analyses

::: columns
::: {.column width="50%"}
<p>[Differentially Methylated (DMRs)]{.highlight}</p>

<br> \* Detects mean difference between tissues <br><br> \* Parameters: 500 bp, <br> min. 4 CpGs, FDR 0.05
:::

::: {.column width="50%"}
<p>[Variably Methylated (VMRs)]{.highlight}</p>

<br> <br> \* Detects difference in variance within a tissue <br><br> \* Parameters: 1000 bp, <br> min. 10 CpGs, C2, FDR 0.05
:::
:::

::: footer
R packages: DMRs - *dmrff*, Suderman, 2018,
:::

---

## Results: Common Effects - DMRs

{fig-align="center"}

---

## Results: *SHANK2* <br>

SH3 and multiple ankyrin repeat domains 2 <br><br>

Synaptic Gene Ontologies Database

<p>[GO terms:]{.highlight}</p>

::: nonincremental
-   postsynaptic density (GO:0014069) <br>
-   regulation of postsynapse organization (GO:0099175) <br>
-   structural constituent of postsynaptic density (GO:0098919) <br> <br>
:::

Using Enrichr for gene set enrichment analysis, we identified significant enrichment of synaptic genes in our dataset. The gene set was sourced from the SynGO 2024 database.

**Citations:** - Enrichr: Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128. doi:10.1186/1471-2105-14-128. - SynGO: Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, et al. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse. Neuron. 2019;103(2):217-234.e4. doi:10.1016/j.neuron.2019.05.002.

::: footer
https://www.syngoportal.org/
:::

---

## Results: The *SHANK2* DMR

![](img/SerumValues_SHANK2.png)

---


## Results: Specific Effects - DMRs<br>

\[\]{width="60%"}

---

## Results: Specific Effects - VMRs<br>

!{width="60%"}

---

## Conclusion

::: incremental
-   The common effects of APs on ***SHANK2*** expression and glutamate receptor function may be mediated by DNAm.

-   Identification of the specific effects may need larger sample sizes.

-   GxE interactions are implicated in up to 75% of VMRs (Epigenomics of Common Diseases 2023).
:::

::: footer
Martens Summer Seminar June 17, 2024
:::

---

## Acknowledgements

St√©phanie, Anne-Kristin, You all!, Have a great summer!

![](img/Watermelon.jpeg){fig-align="center"}

---
